当前位置:
X-MOL 学术
›
Cancer Discov.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Kite, Sangamo Partner on Gene-Edited Cell Therapies
Cancer Discovery ( IF 29.7 ) Pub Date : 2018-04-01 , DOI: 10.1158/2159-8290.cd-nb2018-025 American Association for Cancer Research
中文翻译:
Sangamo Kite,基因编辑细胞疗法合作伙伴
更新日期:2018-04-02
Cancer Discovery ( IF 29.7 ) Pub Date : 2018-04-01 , DOI: 10.1158/2159-8290.cd-nb2018-025 American Association for Cancer Research
Kite and Sangamo signed a deal worth potentially more than $3 billion to jointly develop cellular immunotherapies using zinc finger nuclease gene-editing technologies.
中文翻译:
Sangamo Kite,基因编辑细胞疗法合作伙伴
风筝和Sangamo签署了一项潜在价值超过30亿美元的协议,共同使用锌指核酸酶基因编辑技术开发细胞免疫疗法。